<DOC>
	<DOCNO>NCT00003348</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase I trial study effectiveness carmustine plus O ( 6 ) -benzylguanine treat patient recurrent progressive glioma brain .</brief_summary>
	<brief_title>Carmustine Plus O ( 6 ) -Benzylguanine Treating Patients With Recurrent Progressive Gliomas Brain</brief_title>
	<detailed_description>OBJECTIVES : I . Determine maximum tolerate dose carmustine administer follow O6-benzylguanine patient recurrent , persistent , progressive cerebral anaplastic glioma . II . Characterize toxic effect associate treatment regimen patient . III . Observe patient clinical antitumor response treat regimen . OUTLINE : Patients stratify accord prior nitrosourea administration ( yes ) . ( Prior nitrosoureas stratum close ) An initial cohort 3 patient per stratum treat intravenous O6-benzylguanine follow approximately 1 hour later intravenous carmustine every 6 week . Additional cohort 3-6 patient treat escalate dos carmustine dose limit toxicity ( DLT ) observe . The maximum tolerate dose define dose 1 6 patient experience DLT . Courses repeat every 6 week absence disease progression unacceptable toxicity . PROJECTED ACCRUAL : A total 24-56 patient ( 12-28 per stratum ) accrue 12 month .</detailed_description>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Carmustine</mesh_term>
	<mesh_term>O ( 6 ) -benzylguanine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven recurrent , persistent , progressive glioblastoma multiforme anaplastic astrocytoma diagnose biopsy/resection Evaluable residual disease MRI CT scan PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 60100 % Life expectancy : Not specify Hematopoietic : Absolute granulocyte count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : SGOT great 2.5 time upper limit normal Bilirubin within normal limit Renal : Creatinine great 1.5 mg/dL OR Creatinine clearance great 60 mL/min BUN great 25 mg/dL Pulmonary : DLCO great 80 % predict Other : Not pregnant nursing Fertile patient must use effective contraceptive method 2 month study PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : At least 4 week since prior chemotherapy ( 6 week since prior nitrosourea , procarbazine , mitomycin ) recover Endocrine therapy : Concurrent corticosteroid therapy must stable least 1 week prior study , clinically possible Radiotherapy : At least 4 week since prior radiotherapy recover Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>